Recently, Hainan Cancer Hospital introduced an innovative technology called "high-precision whole-genome testing”. This testing technology is not only capable of predicting disease risks but can also detect innate talents in children, including accurately assessing whether your child is suitable for learning the piano, for example.
It is a scientific approach instead of mysticism.
With the exception of trauma, almost all diseases are related to genes
"Human genes are like a complex codebook, with each individual having their unique genetic code." Dr. Xu Xianhua, Director of the Pathology Department of the hospital, explained that modern medical research has shown that, except for trauma, almost all diseases are associated with genes.
It is reported that "high-precision whole-genome testing" is an advanced technology in high-throughput sequencing. It is available in both adult and pediatric versions, and it can sequence and analyze the complete genome sequence of the individual being tested according to their specific needs. It includes the assessment of disease risk genes, precision medicine genes, and personalized trait genes (including nutrition, personalized characteristics, weight management, exercise, beauty). Among them, the pediatric version includes the assessment and analysis of genes related to nutrition absorption, intelligence, emotional intelligence, physical activity, and arts.
Leveraging big data to achieve prospective precision analysis
Dr. Xu Xianhua introduced that after obtaining the genetic data of the subjects, "high-precision whole-genome testing" conducts screening, comparison, analysis, and generates reports through a large gene database. What sets it apart from other genetic sequencing technologies is its strong database support.
The big data system includes cutting-edge international research findings, selects research conclusions specific to Asian populations, and integrates databases on human genetic disease mutations, human Mendelian genetic database, cancer somatic mutation database, etc. With the help of modern massive genetic variant data, it provides subjects with prospective precision analysis and assessment for health management.
Not only predicting disease risks, but also predicting talents
Dr. Xu Xianhua stated that "high-precision whole-genome testing" technology can predict the risk of challenging and complex chronic diseases such as cancer and Alzheimers disease. It also provides a clear evaluation of individual physical constitution analysis and medication guidance. Therefore, it is a good testing option for individuals with a family history of malignant tumors or other challenging and complex genetic diseases.
Even more fascinatingly, genetic testing for children allows for scientific analysis and evaluation of their congenital nutritional metabolism capacity, disease susceptibility, and individual talents. Parents can not only understand their childs future health status but also anticipate their "genetic code" for financial intelligence, creative ability, learning aptitude, musical talent, and more. As a result, through forward-looking analysis, parents can have early knowledge of whether their child is suitable for activities such as learning the piano. Based on the genetic code, parents can accurately plan their childs future development and successfully "avoid pitfalls" in terms of educational investment and life direction.
Human genes are "innate" . Therefore, genetic testing only needs to be done once in a lifetime. Xu Xianhua pointed out that genetic testing is not a folk fortune-telling or character analysis. It has comprehensive, scientific, accurate, and reliable testing technological advantages. The results are highly credible and can be used not only for clinical treatment guidance but also for early interventions to reduce or avoid disease risks.
Dr. Xu Xianhua (front middle) discussing with her team.
Introduction of the expert
Introduction of Pathology Department
The Pathology Department is equipped with world-class pathology diagnostic facilities and has established a comprehensive diagnostic platform that combines pathological morphology, immunohistochemistry, and molecular pathology techniques. The department can perform routine paraffin and frozen section diagnosis, exfoliative cytology and fine needle aspiration cytology diagnosis, immunohistochemistry diagnosis, molecular pathology diagnosis, and challenging pathological consultation services.
The Pathology Department provides efficient and timely comprehensive precision diagnostic services for clinical precision treatment. The overall discipline of medical technology and academic level is at the forefront domestically and internationally. Currently, it can carry out internationally leading tumor gene detection technologies, such as first-generation and second-generation sequencing. The service projects mainly focus on four areas: 1. Personalized medication guidance and auxiliary diagnosis for tumors: By molecular typing of tumors, searching for causes, identifying drug targets, and interpreting the relationship between drugs and genes, it assists doctors in formulating individualized treatment plans. 2. Conventional medication guidance for tumors. 3. Prognostic monitoring of tumor treatment: Based on liquid biopsy techniques such as circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs), which are non-invasive and higher sensitivity, they can reflect the progression of tumors and treatment effects earlier. 4. Early screening of tumors and testing of susceptibility genes for tumors: Used for early detection, prevention, and screening of hereditary tumors.
Further reading
Gene Screening: The "Gold Key" to Cancer Prevention
Next and picture from Liang Shan